Mei Zhang; Limin Wang; Xiao Zhang; Chun Li; Zhenping Zhao; Mengting Yu; Maigeng Zhou; Jing Wu; Linhong Wang; Mei Zhang; Limin Wang; Xiao Zhang; Chun Li; Zhenping Zhao; Mengting Yu; Maigeng Zhou; Jing Wu; Linhong Wang

doi:10.46234/ccdcw2025.052

[1]

Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8(2):e191 − 203. https://doi.org/10.1016/S2214-109X(21)00554-4.

[2]

Wu J, Jin QY, Zhang YM, Ji YT, Li JJ, Liu XM, et al. Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022. Journal of the National Cancer Center. 2025 (In press). https://doi.org/10.1016/j.jncc.2024.11.006.

[3]

World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020. https://iris.who.int/bitstream/handle/10665/336583/9789240014107-eng.pdf?sequence=1. [2025-01-04]

[4]

Notice of the General Office of the National Health Commission on Released the Work Plan for Cervical Cancer Screening and Breast Cancer Screening. http://www.nhc.gov.cn/fys/s3581/202201/cad44d88acca4ae49e12dab9176ae21c.shtml. [2025-01-04].

[5]

Zhang M, Zhong YJ, Wang LM, Bao HL, Huang ZJ, Zhao ZP, et al. Cervical cancer screening coverage - China, 2018-2019. China CDC Wkly 2022;4(48):1077 − 82. https://doi.org/10.46234/ccdcw2022.217.

[6]

Zhang M, Zhong YJ, Zhao ZP, Huang ZJ, Zhang X, Li C, et al. Cervical cancer screening rates among Chinese women - China, 2015. China CDC Wkly 2020;2(26):481 − 6. https://doi.org/10.46234/ccdcw2020.128.

[7]

Zhang M, Wang LH, Wu J, Huang ZJ, Zhao ZP, Zhang X, et al. Data resource profile: China chronic disease and risk factor surveillance (CCDRFS). Int J Epidemiol 2022;51(2):e1 − 8. https://doi.org/10.1093/ije/dyab255.

[8]

Wang LM, Xu X, Zhang M, Hu CH, Zhang X, Li C, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med 2023;183(4):298 − 310. https://doi.org/10.1001/jamainternmed.2022.6817.

[9]

Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health 2022;10(8):e1115 − 27. https://doi.org/10.1016/S2214-109X(22)00241-8.

[10]

Fernández-Deaza G, Serrano B, Roura E, Castillo JS, Caicedo-Martínez M, Bruni L, et al. Cervical cancer screening coverage in the Americas region: a synthetic analysis. Lancet Reg Health Am 2024;30:100689. https://doi.org/10.1016/j.lana.2024.100689.